About TLR Therapeutics
TLR Therapeutics is a company based in Wilmington (United States) founded in 2022. It operates as a B2B. TLR Therapeutics operates in a competitive market with competitors including Intima Bioscience, Draconis Pharma, Ilico Genetics, Shgsmed.com and Checkmate Therapeutics, among others.
- Headquarter Wilmington, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of TLR Therapeutics
Detailed funding history for TLR Therapeutics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by TLR Therapeutics
Investment portfolio details for TLR Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - TLR Therapeutics
Detailed financials for TLR Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Tlr Therapeutics Comparisons
Peer comparison for TLR Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of TLR Therapeutics
TLR Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Intima Bioscience, Draconis Pharma, Ilico Genetics, Shgsmed.com and Checkmate Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for gastrointestinal cancer are developed using CRISPR gene-editing.
|
|
| Locked | Locked | Locked |
Therapeutic solutions for cancer, pain, and immune diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of diagostic test for detection of gastric cancer
|
|
| Locked | Locked | Locked |
Drugs for esophageal cancer treatment are developed using photodynamic therapy.
|
|
| Locked | Locked | Locked |
Develops innovative therapeutic technologies for cancer and neurological disorders.
|
Detailed competitors of TLR Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Tlr Therapeutics
Complete news archive for TLR Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TLR Therapeutics
TLR Therapeutics was founded in 2022.
TLR Therapeutics is headquartered in Wilmington, United States. It is registered at Wilmington, Delaware, United States.
TLR Therapeutics, established in 2022, excels in providing healthcare solutions, advancing biotech innovations, therapeutics, and cancer treatment. Develops innovative therapeutics for treating myelodysplastic syndrome and gastric cancer. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
TLR Therapeutics's top competitors include Draconis Pharma, Ilico Genetics and Intima Bioscience.